These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 10815157

  • 1. Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys.
    Obana A, Gohto Y, Kanai M, Nakajima S, Kaneda K, Miki T.
    Arch Ophthalmol; 2000 May; 118(5):650-8. PubMed ID: 10815157
    [Abstract] [Full Text] [Related]

  • 2. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.
    Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T.
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2639-45. PubMed ID: 11581211
    [Abstract] [Full Text] [Related]

  • 3. Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.
    Obana A, Gohto Y, Kaneda K, Nakajima S, Takemura T, Miki T.
    Lasers Surg Med; 1999 Oct; 24(3):209-22. PubMed ID: 10229152
    [Abstract] [Full Text] [Related]

  • 4. [Effect of photodynamic therapy with ATX-S 10 (Na) on experimental choroidal neovascularization].
    Hirose T, Nakajima M, Kyou T, Yuzawa M.
    Nippon Ganka Gakkai Zasshi; 2006 Jun; 110(6):445-53. PubMed ID: 16808159
    [Abstract] [Full Text] [Related]

  • 5. Scanning laser system for photodynamic therapy of choroidal neovascularization.
    Obana A, Gohto Y.
    Lasers Surg Med; 2002 Jun; 30(5):370-5. PubMed ID: 12116330
    [Abstract] [Full Text] [Related]

  • 6. Long-term effectiveness of photodynamic therapy by using a hydrophilic photosensitizer ATX-S10(Na) against experimental choroidal neovascularization in rats.
    Kanai M, Obana A, Gohto Y, Nagata S, Miki T, Kaneda K, Nakajima S.
    Lasers Surg Med; 2000 Jun; 26(1):48-57. PubMed ID: 10637003
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [Abstract] [Full Text] [Related]

  • 11. Sequence of early vascular events after photodynamic therapy.
    Michels S, Schmidt-Erfurth U.
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2147-54. PubMed ID: 12714655
    [Abstract] [Full Text] [Related]

  • 12. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
    Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES.
    Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
    [Abstract] [Full Text] [Related]

  • 13. Dynamic observation of selective accumulation of a photosensitizer and its photodynamic effects in rat experimental choroidal neovascularization.
    Hikichi T, Mori F, Nakajima S, Takamiya TA, Takeda M, Sasaki M, Horikawa Y, Yoshida A.
    Retina; 2001 Sep; 21(2):126-31. PubMed ID: 11321138
    [Abstract] [Full Text] [Related]

  • 14. Comparative study of the phototoxicity of two chrolin type photosensitizers, ATX-S10(Na) and verteporfin, on vascular endothelial and retinal pigment epithelial cells.
    Huang Y, Obana A, Gohto Y, Nakajima S.
    Lasers Surg Med; 2004 Sep; 34(3):216-26. PubMed ID: 15022248
    [Abstract] [Full Text] [Related]

  • 15. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ, Terada Y, Haddadin MJ, Michaud NA, Gragoudas ES, Miller JW.
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [Abstract] [Full Text] [Related]

  • 16. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
    Kramer M, Miller JW, Michaud N, Moulton RS, Hasan T, Flotte TJ, Gragoudas ES.
    Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
    Husain D, Kim I, Gauthier D, Lane AM, Tsilimbaris MK, Ezra E, Connolly EJ, Michaud N, Gragoudas ES, O'Neill CA, Beyer JC, Miller JW.
    Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
    [Abstract] [Full Text] [Related]

  • 18. Anastomotic vessels remain viable after photodynamic therapy in primate models of choroidal neovascularization.
    Criswell MH, Ciulla TA, Lowseth LA, Small W, Danis RP, Carson DL.
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2168-74. PubMed ID: 15914638
    [Abstract] [Full Text] [Related]

  • 19. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
    Zacks DN, Ezra E, Terada Y, Michaud N, Connolly E, Gragoudas ES, Miller JW.
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
    [Abstract] [Full Text] [Related]

  • 20. Photodynamic therapy of experimental choroidal neovascularization in the mouse.
    Odergren A, Ming Y, Kvanta A.
    Curr Eye Res; 2006 Sep; 31(9):765-74. PubMed ID: 16966149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.